Literature DB >> 11803083

Protection induced by intramuscular immunization with DNA vaccines of pseudorabies in mice, rabbits and piglets.

Wenzhou Hong1, Shaobo Xiao, Rui Zhou, Liurong Fang, Qigai He, Bin Wu, Fuchun Zhou, Huanchun Chen.   

Abstract

Glycoprotein gene gB, gC and gD of pseudorabies virus (PrV) strain Ea, which was isolated locally in Wuhan, were cloned from the viral genome DNA and expressed in vitro controlled by the major immediately-early promotor/enhancer of HCMV. In the presented paper, Balb/c mice, rabbits and piglets were vaccinated intramuscularly two times at 2-week interval with those eukaryotic expression plasmid pcDB, pcDC and pcDD, respectively. The animals injected with pcDB, pcDC, pcDD or mix DNA developed anti-PrV antibodies. Neutralizing antibody titers obtained 2-5log(2), 2 weeks after the second vaccination. Cellular immune responses were also detected by lymphoproliferation assay and cytotoxic T lymphocyte (CTL) activity assay in all groups vaccinated with DNA. Immune responses elicited by DNA vaccines provided protections with different degrees against lethal dose PrV challenge. In mice, protections induced by pcDC, pcDD or mix DNA were 100%, similar to that by inactivated vaccine. Protections were more than 50% induced by pcDC, pcDD or mix DNA in rabbits. Protections induced by pcDB were the lowest among DNA immunization in mice or rabbits. However, pcDB could elicit the higher cellular responses in rabbits or piglets. In piglets, body temperatures of animals injected with pcDB, pcDC, pcDD or mix DNA did not change significantly after challenge with 2x10(5) pfu of PrV strain Ea, and the means daily growth post-challenge of those animals were higher than those injected with inactivated vaccine or parental plasmid. Neither DNA vaccines nor inactivated vaccine could prevent or delay virus excretion after challenge. Our experiments in experimental animals and natural hosts suggested the efficiency and potential application of DNA vaccines for pseudorabies in pigs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11803083     DOI: 10.1016/s0264-410x(01)00416-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Differential polarization of immune responses by genetic cotransfer of chemokines changes the protective immunity of DNA vaccine against pseudorabies virus.

Authors:  Hyun A Yoon; Seong Kug Eo
Journal:  Immunology       Date:  2006-11-20       Impact factor: 7.397

2.  Use of Staby(®) technology for development and production of DNA vaccines free of antibiotic resistance gene.

Authors:  Anca Reschner; Sophie Scohy; Gaëlle Vandermeulen; Marc Daukandt; Céline Jacques; Benjamin Michel; Hans Nauwynck; Florence Xhonneux; Véronique Préat; Alain Vanderplasschen; Cédric Szpirer
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

3.  Limited protection conferred by a DNA vaccine against a lethal pseudorabies virus infection at day 5 postvaccination.

Authors:  Daniel Dory; Anne-Marie Torché; Véronique Béven; Roland Cariolet; André Jestin
Journal:  Clin Vaccine Immunol       Date:  2007-02-14

4.  Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice.

Authors:  Timo Fischer; Oliver Planz; Lothar Stitz; Hanns-Joachim Rziha
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

5.  Polarization of protective immunity induced by replication-incompetent adenovirus expressing glycoproteins of pseudorabies virus.

Authors:  Young Woo Han; Abi G Aleyas; Junu A George; Seon Ju Kim; Hye Kyung Kim; Hyun A Yoon; Dong Jin Yoo; Seong Ho Kang; Koanhoi Kim; Seong Kug Eo
Journal:  Exp Mol Med       Date:  2008-12-31       Impact factor: 8.718

6.  Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models.

Authors:  Roberto Di Niro; Federica Ziller; Fiorella Florian; Sergio Crovella; Marco Stebel; Marco Bestagno; Oscar Burrone; Andrew R M Bradbury; Paola Secco; Roberto Marzari; Daniele Sblattero
Journal:  BMC Biotechnol       Date:  2007-08-01       Impact factor: 2.563

7.  Systematic review of animal-based indicators to measure thermal, social, and immune-related stress in pigs.

Authors:  Raúl David Guevara; Jose J Pastor; Xavier Manteca; Gemma Tedo; Pol Llonch
Journal:  PLoS One       Date:  2022-05-05       Impact factor: 3.752

8.  Efficacy of a gB + gD-based subunit vaccine and the adjuvant granulocyte-macrophage colony stimulating factor for pseudorabies virus in rabbits.

Authors:  Zhi Cao; Ke Zhang; Heng Zhang; Hongliang Zhang; Ying Yu; Dehua Yin; Hu Shan; Zhihua Qin
Journal:  Front Microbiol       Date:  2022-08-03       Impact factor: 6.064

9.  Therapeutic Strategy for the Prevention of Pseudorabies Virus Infection in C57BL/6 Mice by 3D8 scFv with Intrinsic Nuclease Activity.

Authors:  Gunsup Lee; SeungChan Cho; Phuong Mai Hoang; Dongjun Kim; Yongjun Lee; Eui-Joon Kil; Sung-June Byun; Taek-Kyun Lee; Dae-Hyun Kim; Sunghan Kim; Sukchan Lee
Journal:  Mol Cells       Date:  2015-08-07       Impact factor: 5.034

10.  Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus.

Authors:  Yuting Pan; Renyong Jia; Juping Li; Mingshu Wang; Shun Chen; Mafeng Liu; Dekang Zhu; Xinxin Zhao; Ying Wu; Qiao Yang; Zhongqiong Yin; Bo Jing; Juan Huang; Shaqiu Zhang; Lin Zhang; Yunya Liu; Yanlin Yu; Bin Tian; Leichang Pan; Mujeeb Ur Rehman; Anchun Cheng
Journal:  Virol J       Date:  2020-05-12       Impact factor: 4.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.